FY2019 EPS Estimates for Aphria Inc Lowered by Seaport Global Securities (APHA)
Aphria Inc (NYSE:APHA) – Equities researchers at Seaport Global Securities cut their FY2019 earnings per share (EPS) estimates for shares of Aphria in a research note issued to investors on Monday, April 15th. Seaport Global Securities analyst B. Hundley now forecasts that the company will post earnings of ($0.15) per share for the year, down from their previous forecast of $0.17. Seaport Global Securities currently has a “Buy” rating and a $18.00 target price on the stock. Seaport Global Securities also issued estimates for Aphria’s Q4 2019 earnings at ($0.05) EPS, Q2 2020 earnings at ($0.03) EPS and FY2020 earnings at ($0.01) EPS.
APHA has been the subject of several other reports. Cormark set a $15.00 target price on Aphria and gave the company a “buy” rating in a research report on Saturday, February 2nd. CIBC started coverage on Aphria in a research report on Friday, January 18th. They issued a “neutral” rating for the company. Clarus Securities started coverage on Aphria in a research report on Tuesday. They issued a “buy” rating and a $22.75 target price for the company. ValuEngine raised Aphria from a “hold” rating to a “buy” rating in a research report on Monday, April 1st. Finally, Zacks Investment Research downgraded Aphria from a “hold” rating to a “sell” rating in a research report on Friday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company. Aphria has a consensus rating of “Hold” and a consensus target price of $15.69.
Several institutional investors and hedge funds have recently made changes to their positions in APHA. Winslow Evans & Crocker Inc. purchased a new position in shares of Aphria in the 4th quarter valued at about $28,000. Intercontinental Wealth Advisors LLC purchased a new position in shares of Aphria in the 4th quarter valued at about $28,000. Liberty Wealth Management LLC purchased a new position in shares of Aphria in the 4th quarter valued at about $35,000. 1832 Asset Management L.P. purchased a new position in shares of Aphria in the 4th quarter valued at about $50,000. Finally, Truvestments Capital LLC purchased a new position in shares of Aphria in the 1st quarter valued at about $61,000. Institutional investors and hedge funds own 10.39% of the company’s stock.
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.
Further Reading: How Does the Quiet Period Work?
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.